Annual Current Liabilities
$467.80 M
-$55.00 M-10.52%
December 31, 2024
Summary
- As of February 26, 2025, BIO annual total current liabilities is $467.80 million, with the most recent change of -$55.00 million (-10.52%) on December 31, 2024.
- During the last 3 years, BIO annual current liabilities has fallen by -$213.14 million (-31.30%).
- BIO annual current liabilities is now -48.34% below its all-time high of $905.50 million, reached on December 31, 2019.
Performance
BIO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$467.80 M
-$30.14 M-6.05%
December 31, 2024
Summary
- As of February 26, 2025, BIO quarterly total current liabilities is $467.80 million, with the most recent change of -$30.14 million (-6.05%) on December 31, 2024.
- Over the past year, BIO quarterly current liabilities has increased by +$1.65 million (+0.35%).
- BIO quarterly current liabilities is now -52.59% below its all-time high of $986.66 million, reached on September 30, 2020.
Performance
BIO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
BIO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.5% | +0.3% |
| 3 y3 years | -31.3% | -17.7% |
| 5 y5 years | -48.3% | -17.7% |
BIO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.3% | at low | -31.3% | +0.3% |
| 5 y | 5-year | -48.3% | at low | -52.6% | +0.3% |
| alltime | all time | -48.3% | +2311.3% | -52.6% | +2311.3% |
Bio-Rad Laboratories Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $467.80 M(-10.5%) | $467.80 M(-6.1%) |
| Sep 2024 | - | $497.94 M(+2.3%) |
| Jun 2024 | - | $486.96 M(+4.5%) |
| Mar 2024 | - | $466.15 M(-10.8%) |
| Dec 2023 | $522.80 M(-8.1%) | $522.80 M(-6.3%) |
| Sep 2023 | - | $558.18 M(-4.1%) |
| Jun 2023 | - | $581.98 M(-1.3%) |
| Mar 2023 | - | $589.62 M(+3.7%) |
| Dec 2022 | $568.71 M(-16.5%) | $568.71 M(-0.3%) |
| Sep 2022 | - | $570.68 M(-7.0%) |
| Jun 2022 | - | $613.71 M(-5.3%) |
| Mar 2022 | - | $648.33 M(-4.8%) |
| Dec 2021 | $680.94 M(+7.8%) | $680.94 M(+4.8%) |
| Sep 2021 | - | $649.92 M(+10.7%) |
| Jun 2021 | - | $587.05 M(-3.7%) |
| Mar 2021 | - | $609.89 M(-3.4%) |
| Dec 2020 | $631.54 M(-30.3%) | $631.54 M(-36.0%) |
| Sep 2020 | - | $986.66 M(+6.4%) |
| Jun 2020 | - | $926.89 M(+6.6%) |
| Mar 2020 | - | $869.25 M(-4.0%) |
| Dec 2019 | $905.50 M(+100.9%) | $905.50 M(+108.6%) |
| Sep 2019 | - | $434.04 M(-2.7%) |
| Jun 2019 | - | $445.98 M(+0.4%) |
| Mar 2019 | - | $444.31 M(-1.4%) |
| Dec 2018 | $450.80 M(-10.3%) | $450.80 M(-0.5%) |
| Sep 2018 | - | $453.16 M(+2.4%) |
| Jun 2018 | - | $442.42 M(-3.0%) |
| Mar 2018 | - | $456.20 M(-9.2%) |
| Dec 2017 | $502.70 M(+6.7%) | $502.70 M(+7.8%) |
| Sep 2017 | - | $466.46 M(+2.5%) |
| Jun 2017 | - | $455.11 M(+11.7%) |
| Mar 2017 | - | $407.50 M(-13.5%) |
| Dec 2016 | $471.32 M(+6.8%) | $471.32 M(+6.5%) |
| Sep 2016 | - | $442.72 M(+7.9%) |
| Jun 2016 | - | $410.40 M(+2.4%) |
| Mar 2016 | - | $400.89 M(-9.2%) |
| Dec 2015 | $441.35 M(-1.2%) | $441.35 M(+1.4%) |
| Sep 2015 | - | $435.24 M(+7.8%) |
| Jun 2015 | - | $403.89 M(-3.1%) |
| Mar 2015 | - | $416.88 M(-6.7%) |
| Dec 2014 | $446.76 M(-8.4%) | $446.76 M(-11.3%) |
| Sep 2014 | - | $503.78 M(+4.9%) |
| Jun 2014 | - | $480.25 M(-0.2%) |
| Mar 2014 | - | $481.25 M(-1.3%) |
| Dec 2013 | $487.47 M(+3.2%) | $487.47 M(+5.3%) |
| Sep 2013 | - | $462.88 M(+7.3%) |
| Jun 2013 | - | $431.24 M(-3.5%) |
| Mar 2013 | - | $446.74 M(-5.4%) |
| Dec 2012 | $472.40 M(+2.9%) | $472.40 M(+8.9%) |
| Sep 2012 | - | $433.67 M(+4.0%) |
| Jun 2012 | - | $417.18 M(-6.1%) |
| Mar 2012 | - | $444.08 M(-3.3%) |
| Dec 2011 | $459.12 M(-31.1%) | $459.12 M(+10.5%) |
| Sep 2011 | - | $415.33 M(-6.2%) |
| Jun 2011 | - | $442.84 M(+3.6%) |
| Mar 2011 | - | $427.59 M(-35.9%) |
| Dec 2010 | $666.63 M(+58.7%) | $666.63 M(+62.3%) |
| Sep 2010 | - | $410.69 M(+5.4%) |
| Jun 2010 | - | $389.50 M(-2.2%) |
| Mar 2010 | - | $398.17 M(-5.2%) |
| Dec 2009 | $419.97 M(+0.5%) | $419.97 M(+1.0%) |
| Sep 2009 | - | $415.69 M(+8.4%) |
| Jun 2009 | - | $383.61 M(+7.8%) |
| Mar 2009 | - | $355.88 M(-14.9%) |
| Dec 2008 | $418.03 M(+0.9%) | $418.03 M(+8.4%) |
| Sep 2008 | - | $385.81 M(-5.5%) |
| Jun 2008 | - | $408.09 M(+5.3%) |
| Mar 2008 | - | $387.45 M(-6.5%) |
| Dec 2007 | $414.17 M(+29.6%) | $414.17 M(+44.6%) |
| Sep 2007 | - | $286.46 M(+1.6%) |
| Jun 2007 | - | $281.85 M(+3.6%) |
| Mar 2007 | - | $272.09 M(-14.8%) |
| Dec 2006 | $319.53 M | $319.53 M(+13.6%) |
| Sep 2006 | - | $281.31 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $281.02 M(+8.4%) |
| Mar 2006 | - | $259.13 M(-18.8%) |
| Dec 2005 | $319.24 M(+1.2%) | $319.24 M(+6.7%) |
| Sep 2005 | - | $299.23 M(+2.9%) |
| Jun 2005 | - | $290.85 M(-2.6%) |
| Mar 2005 | - | $298.48 M(-5.4%) |
| Dec 2004 | $315.38 M(+31.8%) | $315.38 M(+15.8%) |
| Sep 2004 | - | $272.37 M(+29.0%) |
| Jun 2004 | - | $211.14 M(-4.5%) |
| Mar 2004 | - | $221.20 M(-7.5%) |
| Dec 2003 | $239.25 M(+7.8%) | $239.25 M(+3.0%) |
| Sep 2003 | - | $232.33 M(+6.0%) |
| Jun 2003 | - | $219.12 M(+0.9%) |
| Mar 2003 | - | $217.19 M(-2.2%) |
| Dec 2002 | $222.01 M(+11.5%) | $222.01 M(+4.4%) |
| Sep 2002 | - | $212.58 M(+4.9%) |
| Jun 2002 | - | $202.70 M(+4.2%) |
| Mar 2002 | - | $194.45 M(-2.3%) |
| Dec 2001 | $199.11 M(+5.2%) | $199.11 M(-7.3%) |
| Sep 2001 | - | $214.69 M(+6.7%) |
| Jun 2001 | - | $201.21 M(+5.1%) |
| Mar 2001 | - | $191.54 M(+1.2%) |
| Dec 2000 | $189.31 M(-6.5%) | $189.31 M(+3.0%) |
| Sep 2000 | - | $183.82 M(-3.9%) |
| Jun 2000 | - | $191.23 M(+2.8%) |
| Mar 2000 | - | $185.95 M(-8.2%) |
| Dec 1999 | $202.50 M(+108.3%) | $202.50 M(+119.9%) |
| Sep 1999 | - | $92.10 M(+8.1%) |
| Jun 1999 | - | $85.20 M(-5.2%) |
| Mar 1999 | - | $89.90 M(-7.5%) |
| Dec 1998 | $97.20 M(-3.6%) | $97.20 M(+3.0%) |
| Sep 1998 | - | $94.40 M(-0.6%) |
| Jun 1998 | - | $95.00 M(-3.6%) |
| Mar 1998 | - | $98.50 M(-2.3%) |
| Dec 1997 | $100.80 M(+27.4%) | $100.80 M(+19.4%) |
| Sep 1997 | - | $84.40 M(+6.0%) |
| Jun 1997 | - | $79.60 M(-4.9%) |
| Mar 1997 | - | $83.70 M(+5.8%) |
| Dec 1996 | $79.10 M(-11.9%) | $79.10 M(+5.3%) |
| Sep 1996 | - | $75.10 M(-8.5%) |
| Jun 1996 | - | $82.10 M(-5.1%) |
| Mar 1996 | - | $86.50 M(-3.7%) |
| Dec 1995 | $89.80 M(-0.1%) | $89.80 M(+3.1%) |
| Sep 1995 | - | $87.10 M(-11.3%) |
| Jun 1995 | - | $98.20 M(-3.5%) |
| Mar 1995 | - | $101.80 M(+13.2%) |
| Dec 1994 | $89.90 M(+2.9%) | $89.90 M(-3.1%) |
| Sep 1994 | - | $92.80 M(-0.5%) |
| Jun 1994 | - | $93.30 M(+3.8%) |
| Mar 1994 | - | $89.90 M(+2.9%) |
| Dec 1993 | $87.40 M(-11.2%) | $87.40 M(-27.1%) |
| Sep 1993 | - | $119.90 M(-6.0%) |
| Jun 1993 | - | $127.50 M(+31.0%) |
| Mar 1993 | - | $97.30 M(-1.1%) |
| Dec 1992 | $98.40 M(+6.8%) | $98.40 M(-6.9%) |
| Sep 1992 | - | $105.70 M(-16.8%) |
| Jun 1992 | - | $127.10 M(+34.6%) |
| Mar 1992 | - | $94.40 M(+2.5%) |
| Dec 1991 | $92.10 M(+8.9%) | $92.10 M(+4.3%) |
| Sep 1991 | - | $88.30 M(-1.3%) |
| Jun 1991 | - | $89.50 M(+1.7%) |
| Mar 1991 | - | $88.00 M(+4.0%) |
| Dec 1990 | $84.60 M(+13.9%) | $84.60 M(+11.5%) |
| Sep 1990 | - | $75.90 M(-3.1%) |
| Jun 1990 | - | $78.30 M(+4.4%) |
| Mar 1990 | - | $75.00 M(+0.9%) |
| Dec 1989 | $74.30 M(+39.1%) | $74.30 M(+10.2%) |
| Sep 1989 | - | $67.40 M(+11.2%) |
| Jun 1989 | - | $60.60 M(+13.5%) |
| Dec 1988 | $53.40 M(+17.6%) | $53.40 M(+17.6%) |
| Dec 1987 | $45.40 M(+38.8%) | $45.40 M(+38.8%) |
| Dec 1986 | $32.70 M(+36.8%) | $32.70 M(+36.8%) |
| Dec 1985 | $23.90 M(+23.2%) | $23.90 M(+23.2%) |
| Dec 1984 | $19.40 M | $19.40 M |
FAQ
- What is Bio-Rad Laboratories annual total current liabilities?
- What is the all time high annual current liabilities for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual current liabilities year-on-year change?
- What is Bio-Rad Laboratories quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly current liabilities year-on-year change?
What is Bio-Rad Laboratories annual total current liabilities?
The current annual current liabilities of BIO is $467.80 M
What is the all time high annual current liabilities for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual total current liabilities is $905.50 M
What is Bio-Rad Laboratories annual current liabilities year-on-year change?
Over the past year, BIO annual total current liabilities has changed by -$55.00 M (-10.52%)
What is Bio-Rad Laboratories quarterly total current liabilities?
The current quarterly current liabilities of BIO is $467.80 M
What is the all time high quarterly current liabilities for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly total current liabilities is $986.66 M
What is Bio-Rad Laboratories quarterly current liabilities year-on-year change?
Over the past year, BIO quarterly total current liabilities has changed by +$1.65 M (+0.35%)